Literature DB >> 11465791

Neuroendoscopic third ventriculostomy in dysmorphic brains.

M Cartmill1, T Jaspan, N McConachie, M Vloeberghs.   

Abstract

Neuroendoscopic third ventriculostomy (NTV) has superseded shunting as the treatment of choice in non-communicating hydrocephalus. Intracranial developmental anomalies have been considered to be relative contraindications for this procedure. We present one patient with a Dandy-Walker malformation and another with septo-optic dysplasia who presented with hydrocephalus. An NTV was performed successfully in both patients using a flexible neuroendoscope and utilising transendoscopic Doppler ultrasound to ensure a safe target area for ventriculostomy.

Entities:  

Mesh:

Year:  2001        PMID: 11465791     DOI: 10.1007/s003810000438

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  4 in total

1.  Success of endoscopic third ventriculostomy in children less than 2 years of age.

Authors:  Volkan Etus; Savas Ceylan
Journal:  Neurosurg Rev       Date:  2005-07-22       Impact factor: 3.042

Review 2.  Endoscopic third ventriculostomy for obstructive hydrocephalus.

Authors:  Dieter Hellwig; Joachim Andreas Grotenhuis; Wuttipong Tirakotai; Thomas Riegel; Dirk Michael Schulte; Bernhard Ludwig Bauer; Helmut Bertalanffy
Journal:  Neurosurg Rev       Date:  2004-11-27       Impact factor: 3.042

3.  The role of the Liliequist membrane in the third ventriculostomy.

Authors:  José Aloysio da Costa Val Filho; Sebastião Nataniel da Silva Gusmão; Leopoldo Mandic Ferreira Furtado; Guaracy de Macedo Machado Filho; Fernando Levi Alencar Maciel
Journal:  Neurosurg Rev       Date:  2021-02-23       Impact factor: 3.042

4.  Endoscopic surgical anatomy of the paediatric third ventricle studied using virtual neuroendoscopy based on 3-D ultrasonography.

Authors:  Andreas Jödicke; L Daniel Berthold; Wolfram Scharbrodt; Ilona Schroth; Irwin Reiss; Bernd A Neubauer; Dieter-Karsten Böker
Journal:  Childs Nerv Syst       Date:  2003-05-16       Impact factor: 1.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.